Circulating bronchoepithelial cells expressing mRNA for surfactant protein A in patients with pulmonary fibrosis

Abstract

There are several unsolved clinical findings in patients with idiopathic pulmonary fibrosis (IPF); (i) predominance of fibrosis in the lower lung fields, (ii) digital clubbing, and (iii) patchy distribution of pulmonary fibrosis. To explain these unsolved problems, we hypothesized that regenerated or premature bronchoepithelial cells may circulate in the blood in patients with IPF. To prove this, we performed the reverse transcriptase-polymerase chain reaction (RT-PCR) for cytokeratin 19 (CK19) and pulmonary surfactant protein A (SPA) in peripheral blood in patients with IPF and pulmonary fibrosis associated with collagen vascular disorders. In addition, 20 patients with chronic pulmonary emphysema as a disease control and 19 normal volunteers were also evaluated for the existence of circulating bronchoepithelial cells.RT-PCR analysis showed that CK19 was expressed in 12 of 38 blood samples (31·6%) of IPF and pulmonary fibrosis associated with collagen vascular disorders, seven of 20 (35·0%) blood samples of chronic pulmonary emphysema, and four of 19 (21·1%) blood samples of normal volunteers. mRNA for SPA was positive in eight of 38 (21·1%) blood samples of IPF. In contrast, SPA expressing cells were not detected in any blood samples obtained from patients with chronic pulmonary emphysema or normal volunteers.This evidence suggests that there were some circulating bronchoepithelial cells expressing mRNA for SPA in peripheral blood of patients with IPF and pulmonary fibrosis associated with collagen vascular disorders.